We are live on ! Find out more
DVAX

Dynavax Technologies

Delisted

DVAX was delisted on the 9th of February, 2026.

111 hedge funds and large institutions have $348M invested in Dynavax Technologies in 2017 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 54 increasing their positions, 22 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

307% more call options, than puts

Call options by funds: $36.4M | Put options by funds: $8.95M

145% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 22

122% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 9

95% more capital invested

Capital invested by funds: $178M → $348M (+$169M)

10% more funds holding

Funds holding: 101111 (+10)

5.44% more ownership

Funds ownership: 68.28%73.71% (+5.4%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
111
Holders Change
+10
Holders Change %
+9.9%
% of All Funds
2.77%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
20
Increased
54
Reduced
22
Closed
9
Calls
$36.4M
Puts
$8.95M
Net Calls
+$27.5M
Net Calls Change
+$19.5M
Name Holding Trade Value Shares
Change
Change in
Stake
Susquehanna International Group
26
Susquehanna International Group
Pennsylvania
$4.37M +$1.52M +234,269 +107%
GPP
27
Great Point Partners
Connecticut
$4.2M +$2.83M +435,500 New
VC
28
Vivo Capital
California
$3.47M -$6 -1 -0%
TCM
29
Tekla Capital Management
Massachusetts
$3.33M
GA
30
Glenhill Advisors
New York
$3.11M -$534K -82,184 -20%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$2.42M +$480K +73,866 +42%
Axa
32
Axa
France
$2.23M +$128K +19,700 +9%
Charles Schwab
33
Charles Schwab
California
$1.75M +$514K +79,141 +78%
Morgan Stanley
34
Morgan Stanley
New York
$1.72M +$404K +62,265 +54%
RSCM
35
Rock Springs Capital Management
Maryland
$1.59M
Group One Trading
36
Group One Trading
Illinois
$1.57M -$234K -36,041 -18%
Russell Investments Group
37
Russell Investments Group
United Kingdom
$1.5M +$195K +30,036 +24%
Creative Planning
38
Creative Planning
Kansas
$1.42M +$934K +143,762 +4,182%
VIA
39
Vident Investment Advisory
Georgia
$1.41M +$946K +145,705 New
TCIM
40
TIAA CREF Investment Management
New York
$1.27M +$185K +28,452 +27%
Hudson Bay Capital Management
41
Hudson Bay Capital Management
Connecticut
$965K +$649K +100,000 New
WMSA
42
Weiss Multi-Strategy Advisers
New York
$965K +$649K +100,000 New
TA
43
Teachers Advisors
New York
$867K +$44.5K +6,855 +8%
California State Teachers Retirement System (CalSTRS)
44
California State Teachers Retirement System (CalSTRS)
California
$840K -$12.3K -1,900 -2%
Allianz Asset Management
45
Allianz Asset Management
Germany
$813K +$81.6K +12,569 +18%
HP
46
Hikari Power
Japan
$808K +$219K +33,755 +68%
FPC
47
Falcon Point Capital
California
$760K -$252K -38,794 -33%
Deutsche Bank
48
Deutsche Bank
Germany
$736K -$479K -73,726 -49%
BBA
49
Baker Bros. Advisors
New York
$724K
Swiss National Bank
50
Swiss National Bank
Switzerland
$685K +$93.5K +14,400 +25%

DVAX Hedge Fund Activity: Q2 2017 in Review

111 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Dynavax Technologies (DVAX) for Q2 2017, worth a combined $348M — up 95% from $178M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new DVAX positions and 9 closed out — a net gain of 11 holders — while 54 added to existing stakes and 22 trimmed.

The largest buyer was PointState Capital, opening a new position worth an estimated $9.09M. The largest seller was Redmile Group, exiting entirely with an estimated $6.07M sold.

  • 111 institutional investors held Dynavax Technologies (DVAX) as of Q2 2017, up from 101 in Q1 2017.
  • Funds reported $348M of Dynavax Technologies stock for Q2 2017, up 95% quarter-over-quarter.
  • 20 funds opened new Dynavax Technologies positions in Q2 2017 and 9 closed out, a net change of +11 holders.
  • The largest Dynavax Technologies buyer in Q2 2017 was PointState Capital, an estimated $9.09M added.
  • The largest Dynavax Technologies seller in Q2 2017 was Redmile Group, an estimated $6.07M sold.

Based on aggregated 13F filings for Q2 2017.